Life Sciences Cases To Watch In The 2nd Half Of 2015
The pharmaceutical industry is poised for important court developments involving off-label marketing, biosimilars exclusivity, False Claims Act liability and the 340B drug-discount program. Here are four cases that attorneys will be...To view the full article, register now.
Already a subscriber? Click here to view full article